Stocks and Investing Stocks and Investing
Thu, January 26, 2023
[ 12:00 AM ] - WOPRAI
Matthew Boss Maintained (BOOT) at Buy with Increased Target to $100 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Jared Shaw Maintained (BOKF) at Buy with Increased Target to $125 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Brady Gailey Maintained (BOKF) at Hold with Increased Target to $110 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
John Freeman Maintained (BSM) at Strong Buy with Decreased Target to $20 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Jeffrey Bernstein Maintained (BROS) at Hold with Increased Target to $31 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
John Freeman Maintained (SM) at Buy with Decreased Target to $45 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Anthony Stoss Maintained (STM) at Strong Buy with Increased Target to $55 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Chris Carey Maintained (STZ) at Buy with Increased Target to $250 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Kevin Cassidy Maintained (STX) at Strong Buy with Increased Target to $75 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Shannon Cross Maintained (STX) at Hold with Increased Target to $69 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Aaron Rakers Maintained (STX) at Hold with Increased Target to $65 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Krish Sankar Maintained (STX) at Buy with Increased Target to $72 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Gus Richard Maintained (STX) at Buy with Increased Target to $74 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Timothy Arcuri Maintained (STX) at Hold with Increased Target to $65 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Corinne Jenkins Maintained (SWTX) at Strong Buy with Increased Target to $45 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Frank Louthan Maintained (T) at Strong Buy with Increased Target to $25 on, Jan 26th, 2023
[ 12:00 AM ] - WOPRAI
Douglas Mitchelson Maintained (T) at Hold with Increased Target to $19 on, Jan 26th, 2023
Wed, January 25, 2023
[ 12:00 AM ] - WOPRAI
Matthew Mishan Initiated (SYK) at Hold on, Jan 25th, 2023
[ 12:00 AM ] - WOPRAI
Mario Lu Maintained (SPOT) at Buy with Decreased Target to $131 on, Jan 25th, 2023
[ 12:00 AM ] - WOPRAI
Doug Anmuth Maintained (SPOT) at Buy with Increased Target to $120 on, Jan 25th, 2023
[ 12:00 AM ] - WOPRAI
Dominick Gabriele Downgraded (SQ) to Hold on, Jan 25th, 2023
[ 12:00 AM ] - WOPRAI
Jason Celino Downgraded (STER) to Hold on, Jan 25th, 2023
[ 12:00 AM ] - WOPRAI
Stephen Scouten Downgraded (SMBK) to Hold and Decreased Target to $28 on, Jan 25th, 2023
[ 12:00 AM ] - WOPRAI
Feddie Strickland Downgraded (SMBK) to Hold and Held Target at $30 on, Jan 25th, 2023
[ 12:00 AM ] - WOPRAI
Stephen Ju Maintained (SNAP) at Buy with Decreased Target to $16 on, Jan 25th, 2023
[ 12:00 AM ] - WOPRAI
Chris Kotowski Maintained (SOFI) at Buy with Decreased Target to $6 on, Jan 25th, 2023
[ 12:00 AM ] - WOPRAI
Nick Setyan Initiated (BROS) at Hold and Held Target at $37 on, Jan 25th, 2023
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Maintained (BRO) at Hold with Decreased Target to $59 on, Jan 25th, 2023
[ 12:00 AM ] - WOPRAI
Walter Spracklin Maintained (CSX) at Buy and Held Target at $35 on, Jan 25th, 2023
[ 12:00 AM ] - WOPRAI
Ed Arce Maintained (CDTX) at Strong Buy with Increased Target to $130 on, Jan 25th, 2023

Ed Arce Maintained (CDTX) at Strong Buy with Increased Target to $130 on, Jan 25th, 2023


Published on 2024-10-28 01:06:42 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy with Increased Target from $120 to $130 on, Jan 25th, 2023.

Ed, nor any peers, have made any analyst calls on CDTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources